| LSS . | 1 minute

Level of investment in Scottish firms in Q2 revealed

Healthcare and biotechnology companies accounted for the lion’s share of the investment with £17m raised. Standout deals in Scotland included £10m raised by Edinburgh-based drug discovery firm AdoRx Therapeutics and £6m by 3F Bio, which creates sustainable protein from renewable sources. Learn more about the investment opportunities in Scottish life sciences here. 

Scottish companies raised £21m in venture capital in the second quarter of 2018, more than double the figure for the previous quarter according to new figures.

The regional trend mirrors the UK story, which also saw healthcare and biotechnology driving some of the top deals.

In total the report found £1.55 billion of venture capital was invested in UK businesses across 244 deals in the last three months, with late-stage financings responsible for the majority of capital invested. The UK also accounted for six of the top ten European deals, including Revolut (£188m) and Freeline Therapeutics (£90m).

See the full story here. 

Back to News

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News
Top